Trade STTK anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Shattuck Labs, Inc. (STTK) is trading at US$6.67, down 1.84% today as of Sep 8, 13:27 EDT. The company has a market capitalisation of US$755.74M. Over the past 52 weeks, STTK has traded between US$1.68 and US$8.33. On Syfe you can trade STTK with $0 commission and add it to your watchlist.
| Previous close | US$6.79 |
|---|---|
| Market cap | US$755.74M |
| 52-week range | US$1.68 – US$8.33 |
| Volume | 677.76K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Shattuck Labs, Inc.
Shattuck Labs, Inc. is a clinical-stage biotechnology company, which engages in the research and development of potential treatments for inflammatory and immune-mediated diseases. It focuses on developing a potential first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company was founded by Josiah C. Hornblower and Taylor Schreiber in 2016 and is headquartered in Austin, TX.
Year: 2020
JPMorgan Initiates Shattuck Labs at Overweight With $10 Price Target
Jul 24, 11:28 AM · MT Newswires
Shattuck Labs Prices $75 Million Public Offering
Jun 10, 10:13 AM · MT Newswires
Shattuck Labs Launches Public Offering of Common Stock
Jun 9, 8:36 PM · MT Newswires
Sector Update: Healthcare Stocks Steady Pre-Bell Monday
Jun 8, 1:20 PM · MT Newswires
Shattuck Labs, Inc. (STTK) stock is trading at US$6.67, -1.84% from the previous close of US$6.79.
The market cap for Shattuck Labs, Inc. (STTK) stock is approximately US$755.74M.
The 52-week high for Shattuck Labs, Inc. (STTK) stock is US$8.33.
The 52-week low for Shattuck Labs, Inc. (STTK) stock is US$1.68.
Shattuck Labs, Inc. (STTK) does not currently pay a dividend.
Stay on top of STTK
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
